Back to Journals » Advances and Applications in Bioinformatics and Chemistry » Volume 6

Approaches to the detection of recessive effects using next generation sequencing data from outbred populations
Authors Curtis D
Received 21 February 2013
Accepted for publication 11 March 2013
Published 11 June 2013 Volume 2013:6 Pages 29—35
DOI https://doi.org/10.2147/AABC.S44332
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
David Curtis
Centre for Psychiatry, Barts and the London School of Medicine and Dentistry, London, UK
Abstract: Conventional methods to analyze genome-wide association studies and whole exome or whole genome sequencing studies would be prone to overlook variants which might exert a recessive effect on risk of disease, either as homozygotes or compound heterozygotes. It is plausible that such effects may be common even in outbred populations. An approach is described which is based on identifying a set of variants in a gene as being potentially of interest and then testing whether there is an excess of cases who are either homozygotes or complex heterozygotes for these variants. Methods based on departure from Hardy–Weinberg equilibrium are more powerful than those which compare cases to controls. However, linkage disequilibrium between variants can be difficult to deal with if phase is unknown. A simple approach for discarding variants apparently in strong linkage disequilibrium with others is proposed. The procedure is simple and quick to apply so can be used in the context of whole genome or exome sequencing studies and is implemented in the SCOREASSOC program.
Keywords: association, sequence, DNA
© 2013 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.